CRYOPORT, INC. Investing Cash Flow
CRYOPORT, INC. (CYRX) reported Investing Cash Flow of $12.90 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-06
- CRYOPORT, INC. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$5.81M, a 102.53% decline year-over-year.
- CRYOPORT, INC. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was $18.72M, a 216.08% increase year-over-year.
- CRYOPORT, INC. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was $56.00K, a 98.39% decline year-over-year.
- CRYOPORT, INC. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was $14.31M, a 90.68% decline year-over-year.
- CRYOPORT, INC. net cash provided by (used in) investing activities for fiscal 2025 was $250.32M, a 41.57% increase from fiscal 2024.
- CRYOPORT, INC. net cash provided by (used in) investing activities for fiscal 2024 was $176.81M, a 390.54% increase from fiscal 2023.
- CRYOPORT, INC. net cash provided by (used in) investing activities for fiscal 2023 was $36.05M.
- CRYOPORT, INC. net cash provided by (used in) investing activities for fiscal 2022 was -$59.68M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 3 month as first filed | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 6 month as first filed | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 9 month as first filed | Net Cash Provided by (Used in) Investing Activities 12 month | Net Cash Provided by (Used in) Investing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$5.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $12.90M 10-Q · filed 2026-08-06 | $12.96M derived: sum of 3 quarters · filed 2026-08-06 | $27.27M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $18.72M 10-Q · filed 2026-05-05 | $18.77M derived: sum of 2 quarters · filed 2026-05-05 | $33.08M derived: sum of 3 quarters · filed 2026-05-05 | $263.12M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $56.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $14.36M derived: sum of 2 quarters · filed 2026-03-05 | $244.40M derived: sum of 3 quarters · filed 2026-08-06 | $250.32M 10-K · filed 2026-03-05 | ||||
| 2025-09-30 | $14.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $244.34M derived: sum of 2 quarters · filed 2026-08-06 | $250.27M 10-Q · filed 2025-11-06 | $253.75M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $230.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $235.96M 10-Q · filed 2026-08-06 | $239.44M derived: sum of 3 quarters · filed 2026-08-06 | $393.01M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $5.92M 10-Q · filed 2026-05-05 | $9.40M derived: sum of 2 quarters · filed 2026-05-05 | $162.97M derived: sum of 3 quarters · filed 2026-05-05 | $176.29M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $3.48M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $157.05M derived: sum of 2 quarters · filed 2026-03-05 | $170.37M derived: sum of 3 quarters · filed 2026-03-05 | $176.81M 10-K · filed 2026-03-05 | ||||
| 2024-09-30 | $153.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $166.89M derived: sum of 2 quarters · filed 2025-11-06 | $173.34M 10-Q · filed 2025-11-06 | $158.58M derived: sum of 4 quarters · filed 2026-03-05 | ||||
| 2024-06-30 | $13.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $19.77M 10-Q · filed 2025-08-12 | $5.01M derived: sum of 3 quarters · filed 2026-03-05 | $23.52M derived: sum of 4 quarters · filed 2026-03-05 | ||||
| 2024-03-31 | $6.45M 10-Q · filed 2025-05-08 | -$8.31M derived: sum of 2 quarters · filed 2026-03-05 | $10.20M derived: sum of 3 quarters · filed 2026-03-05 | $43.87M derived: sum of 4 quarters · filed 2026-03-05 | ||||
| 2023-12-31 | -$14.76M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $3.75M derived: sum of 2 quarters · filed 2026-03-05 | $37.43M derived: sum of 3 quarters · filed 2026-03-05 | $36.05M 10-K · filed 2026-03-05 | ||||
| 2023-09-30 | $18.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $52.19M derived: sum of 2 quarters · filed 2024-11-07 | $50.80M 10-Q · filed 2024-11-07 | $57.93M derived: sum of 4 quarters · filed 2025-03-07 | ||||
| 2023-06-30 | $33.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $32.30M 10-Q · filed 2024-08-08 | $39.42M derived: sum of 3 quarters · filed 2025-03-07 | $33.55M derived: sum of 4 quarters · filed 2025-03-07 | ||||
| 2023-03-31 | -$1.38M 10-Q · filed 2024-05-08 | $5.74M derived: sum of 2 quarters · filed 2025-03-07 | -$124.00K derived: sum of 3 quarters · filed 2025-03-07 | -$64.11M derived: sum of 4 quarters · filed 2025-03-07 | ||||
| 2022-12-31 | $7.12M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $1.26M derived: sum of 2 quarters · filed 2025-03-07 | -$62.73M derived: sum of 3 quarters · filed 2025-03-07 | -$59.68M 10-K · filed 2025-03-07 | ||||
| 2022-09-30 | -$5.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$69.86M derived: sum of 2 quarters · filed 2023-11-09 | -$66.81M 10-Q · filed 2023-11-09 | -$262.78M derived: sum of 4 quarters · filed 2024-03-13 | ||||
| 2022-06-30 | -$63.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$60.94M 10-Q · filed 2023-08-09 | -$256.91M derived: sum of 3 quarters · filed 2024-03-13 | -$283.92M derived: sum of 4 quarters · filed 2024-03-13 | ||||
| 2022-03-31 | $3.05M 10-Q · filed 2023-05-04 | -$192.92M derived: sum of 2 quarters · filed 2024-03-13 | -$219.93M derived: sum of 3 quarters · filed 2024-03-13 | -$250.83M derived: sum of 4 quarters · filed 2024-03-13 | ||||
| 2021-12-31 | -$195.97M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | -$222.98M derived: sum of 2 quarters · filed 2024-03-13 | -$253.88M derived: sum of 3 quarters · filed 2024-03-13 | -$469.25M 10-K · filed 2024-03-13 | ||||
| 2021-09-30 | -$27.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | -$57.91M derived: sum of 2 quarters · filed 2022-11-04 | -$273.28M 10-Q · filed 2022-11-04 | -$656.34M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-06-30 | -$30.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$246.28M 10-Q · filed 2022-08-04 | -$629.34M derived: sum of 3 quarters · filed 2023-02-28 | -$509.00M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-03-31 | -$215.37M 10-Q · filed 2022-05-05 | -$598.43M derived: sum of 2 quarters · filed 2023-02-28 | -$478.09M derived: sum of 3 quarters · filed 2023-02-28 | -$597.14M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2020-12-31 | -$383.06M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$262.72M derived: sum of 2 quarters · filed 2023-02-28 | -$381.77M derived: sum of 3 quarters · filed 2023-02-28 | -$382.31M 10-K · filed 2023-02-28 | ||||
| 2020-09-30 | $120.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $1.29M derived: sum of 2 quarters · filed 2021-11-04 | $748.00K 10-Q · filed 2021-11-04 | $747.95K 10-Q · filed 2020-11-06 | $1.54M derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2020-06-30 | -$119.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | -$119.59M 10-Q · filed 2021-08-06 | -$119.59M 10-Q · filed 2020-08-10 | -$118.80M derived: sum of 3 quarters · filed 2022-02-28 | -$155.45M derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2020-03-31 | -$542.00K 10-Q · filed 2021-05-06 | -$542.48K 10-Q · filed 2020-05-08 | $247.99K derived: sum of 2 quarters · filed 2022-02-28 | -$36.40M derived: sum of 3 quarters · filed 2022-02-28 | -$57.82M derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2019-12-31 | $789.99K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$35.86M derived: sum of 2 quarters · filed 2022-02-28 | -$57.28M derived: sum of 3 quarters · filed 2022-02-28 | -$62.93M 10-K · filed 2022-02-28 | -$62.93M 10-K · filed 2020-03-10 | |||
| 2019-09-30 | -$36.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | -$58.07M derived: sum of 2 quarters · filed 2020-11-06 | -$63.72M 10-Q · filed 2020-11-06 | -$64.82M derived: sum of 4 quarters · filed 2020-11-06 | ||||
| 2019-06-30 | -$21.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$27.07M 10-Q · filed 2020-08-10 | -$28.17M derived: sum of 3 quarters · filed 2020-08-10 | -$38.96M derived: sum of 4 quarters · filed 2020-08-10 | ||||
| 2019-03-31 | -$5.65M 10-Q · filed 2020-05-08 | -$6.75M derived: sum of 2 quarters · filed 2020-05-08 | -$17.54M derived: sum of 3 quarters · filed 2020-05-08 | -$18.25M derived: sum of 4 quarters · filed 2020-05-08 | ||||
| 2018-12-31 | -$1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | -$11.89M derived: sum of 2 quarters · filed 2020-03-10 | -$12.60M derived: sum of 3 quarters · filed 2020-03-10 | -$12.88M 10-K · filed 2020-03-10 | ||||
| 2018-09-30 | -$10.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$11.50M derived: sum of 2 quarters · filed 2019-11-12 | -$11.78M 10-Q · filed 2019-11-12 | -$12.30M derived: sum of 4 quarters · filed 2019-11-12 | ||||
| 2018-06-30 | -$711.36K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | -$996.25K 10-Q · filed 2019-08-09 | -$1.52M derived: sum of 3 quarters · filed 2019-08-09 | -$1.75M derived: sum of 4 quarters · filed 2019-08-09 | ||||
| 2018-03-31 | -$284.89K 10-Q · filed 2019-05-09 | -$804.27K derived: sum of 2 quarters · filed 2019-05-09 | -$1.04M derived: sum of 3 quarters · filed 2019-05-09 | -$1.44M derived: sum of 4 quarters · filed 2019-05-09 | ||||
| 2017-12-31 | -$519.37K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | -$753.53K derived: sum of 2 quarters · filed 2019-03-13 | -$1.16M derived: sum of 3 quarters · filed 2019-03-13 | -$1.80M 10-K · filed 2019-03-13 | ||||
| 2017-09-30 | -$234.16K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$639.92K derived: sum of 2 quarters · filed 2018-11-08 | -$1.28M 10-Q · filed 2018-11-08 | -$1.68M derived: sum of 4 quarters · filed 2018-11-08 | ||||
| 2017-06-30 | -$405.77K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$1.05M 10-Q · filed 2018-08-09 | -$1.44M derived: sum of 3 quarters · filed 2018-08-09 | |||||
| 2017-03-31 | -$641.28K 10-Q · filed 2018-05-03 | -$1.04M derived: sum of 2 quarters · filed 2018-05-03 | ||||||
| 2016-12-31 | -$396.47K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | -$662.67K 10-K · filed 2018-03-08 | -$1.07M 10-K · filed 2018-03-08 | |||||
| 2016-09-30 | -$671.46K 10-Q · filed 2017-11-02 | |||||||
| 2013-12-31 | -$2.04K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-02-13 | -$8.28K derived: sum of 2 quarters · filed 2014-02-13 | -$139.54K 10-Q · filed 2014-02-13 | -$247.06K derived: sum of 4 quarters · filed 2014-02-13 | ||||
| 2013-09-30 | -$6.24K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-11-18 | -$137.50K 10-Q · filed 2013-11-18 | -$245.01K derived: sum of 3 quarters · filed 2013-11-18 | -$269.40K derived: sum of 4 quarters · filed 2014-02-13 | ||||
| 2013-06-30 | -$131.26K 10-Q · filed 2013-08-14 | -$238.78K derived: sum of 2 quarters · filed 2013-08-14 | -$263.16K derived: sum of 3 quarters · filed 2014-02-13 | -$266.07K derived: sum of 4 quarters · filed 2014-02-13 | ||||
| 2013-03-31 | -$107.52K derived: 10-K 12 month − 10-Q 9 month · filed 2013-06-25 | -$131.90K derived: sum of 2 quarters · filed 2014-02-13 | -$134.81K derived: sum of 3 quarters · filed 2014-02-13 | -$178.68K 10-K · filed 2013-06-25 | ||||
| 2012-12-31 | -$24.39K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-02-13 | -$27.29K derived: sum of 2 quarters · filed 2014-02-13 | -$71.17K 10-Q · filed 2014-02-13 | -$90.16K derived: sum of 4 quarters · filed 2014-02-13 | ||||
| 2012-09-30 | -$2.91K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-11-18 | -$46.78K 10-Q · filed 2013-11-18 | -$65.77K derived: sum of 3 quarters · filed 2013-11-18 | -$232.49K derived: sum of 4 quarters · filed 2013-11-18 | ||||
| 2012-06-30 | -$43.87K 10-Q · filed 2013-08-14 | -$62.86K derived: sum of 2 quarters · filed 2013-08-14 | -$229.58K derived: sum of 3 quarters · filed 2013-08-14 | -$362.12K derived: sum of 4 quarters · filed 2013-08-14 | ||||
| 2012-03-31 | -$18.99K derived: 10-K 12 month − 10-Q 9 month · filed 2013-06-25 | -$185.71K derived: sum of 2 quarters · filed 2013-06-25 | -$318.25K derived: sum of 3 quarters · filed 2013-06-25 | -$388.06K 10-K · filed 2013-06-25 | ||||
| 2011-12-31 | -$166.72K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-02-14 | -$299.26K derived: sum of 2 quarters · filed 2013-02-14 | -$369.07K 10-Q · filed 2013-02-14 | -$439.97K derived: sum of 4 quarters · filed 2013-02-14 | ||||
| 2011-09-30 | -$132.54K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-11-09 | -$202.35K 10-Q · filed 2012-11-09 | -$273.26K derived: sum of 3 quarters · filed 2012-11-09 | -$322.78K derived: sum of 4 quarters · filed 2012-11-09 | ||||
| 2011-06-30 | -$69.81K 10-Q · filed 2012-08-14 | -$140.72K derived: sum of 2 quarters · filed 2012-08-14 | -$190.24K derived: sum of 3 quarters · filed 2012-08-14 | -$280.03K derived: sum of 4 quarters · filed 2012-08-14 | ||||
| 2011-03-31 | -$70.90K derived: 10-K 12 month − 10-Q 9 month · filed 2012-06-27 | -$120.43K derived: sum of 2 quarters · filed 2012-06-27 | -$210.22K derived: sum of 3 quarters · filed 2012-06-27 | -$465.45K 10-K · filed 2012-06-27 | ||||
| 2010-12-31 | -$49.52K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-02-21 | -$139.31K derived: sum of 2 quarters · filed 2012-02-21 | -$394.55K 10-Q · filed 2012-02-21 | |||||
| 2010-09-30 | -$89.79K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-11-14 | -$345.02K 10-Q · filed 2011-11-14 | ||||||
| 2010-06-30 | -$255.23K 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |